Keeping You Up To Date

Kinduct Technologies chosen for Canadian chronic disease prevention project

Location name
- April 12, 2016

A national program designed to reduce the social and economic costs of chronic diseases like cancer, cardiovascular disease and diabetes will be powered by Kinduct Technologies.

ACCELERATION is a three-year, $2.4-million project aimed at preventing chronic disease through a motivational program of physical activity, smoking cessation, healthy eating, and alcohol intervention supports  designed and delivered by cardiac rehabilitation and prevention programs and cancer centres in British Columbia, Ontario, Quebec and Nova Scotia.

“Four out of five Canadians are at risk of chronic diseases,” says Dr Paul Oh, principal investigator and Medical Director, Cardiovascular Prevention and Rehabilitation Program at Toronto Rehab. “But most of these diseases can be prevented through healthy lifestyles”.

ACCELERATION takes a multidisciplinary approach, grounded by strategic use of technology, to increase these healthy behaviours. As chronic illness becomes more rampant, the use of time- and resource-saving technologies will be essential to the long-term viability of chronic disease prevention plans.

Kinduct, a proven technology partner in the health and wellness space, will play an important role in ACCELERATION, providing a powerful and secure information exchange between the project teams and the 1000 participants involved in the project. Kinduct’s software platform will provide participants with a tailored exercise program supported by nutritional  information, feedback and encouragement, motivational messaging and behavioural prompts. For the project team, the platform will track and monitor patient activity and progress, providing valuable insights for program development.

“Participants have 24/7 access to the information and motivation they need to follow their health regimes, while the care teams can monitor and measure patient behaviours to ultimately develop a program that creates lasting results,” says Dr Travis McDonough, president and CEO, Kinduct Technologies.

ACCELERATION is funded by the Canadian Partnership Against Cancer (CPAC), Health Canada, and the Heart and Stroke Foundation of Canada.
For more information:
Dr. Travis McDonough, Founder/CEO
Kinduct Technologies Inc.